BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29092047)

  • 1. Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
    Osborn VW; Lee A; Garay E; Safdieh J; Schreiber D
    Neurosurgery; 2018 Nov; 83(5):915-921. PubMed ID: 29092047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.
    Amsbaugh MJ; Yusuf M; Gaskins J; Burton E; Woo S
    J Clin Neurosci; 2019 Aug; 66():92-99. PubMed ID: 31104962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
    Malakhov N; Lee A; Garay E; Becker DJ; Schreiber D
    J Clin Neurosci; 2018 Jun; 52():66-70. PubMed ID: 29576419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.
    Han SJ; Rutledge WC; Molinaro AM; Chang SM; Clarke JL; Prados MD; Taylor JW; Berger MS; Butowski NA
    Neurosurgery; 2015 Aug; 77(2):248-53; discussion 253. PubMed ID: 25856113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
    Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center.
    Magrowski Ł; Nowicka E; Masri O; Tukiendorf A; Tarnawski R; Miszczyk M
    J Clin Neurosci; 2021 Aug; 90():39-47. PubMed ID: 34275579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
    Zhu P; Du XL; Zhu JJ; Esquenazi Y
    J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
    Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
    Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
    Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival improvements with adjuvant therapy in patients with glioblastoma.
    Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF
    ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
    Amin S; Baine M; Meza J; Alam M; Lin C
    Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
    De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
    Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.